New Market Research Report: Kenya Pharmaceuticals & Healthcare Report Q1 2016
Headline Expenditure Projections
Pharmaceuticals: KES63.75bn (
Healthcare: KES190.34bn (
Risk/Reward Index
In BMI's Q415 Pharmaceutical and Healthcare Risk/Reward Index,
Get More Details on this Report and a Full Table of Contents at Kenya Pharmaceuticals & Healthcare Report Q1 2016
Key Trends And Developments
In
In
Key Benefits
-Benchmark BMI's pharmaceutical and healthcare market forecasts for
-Target business opportunities and risks in the Kenyan pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in
-Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.
Coverage
BMI Industry View
An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI?s forecast analysis, and taken together with BMI?s political, economic and business environment SWOTs, it gives a complete overview of market climate.
BMI Industry Forecast Scenario
Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:
-Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per ?000 population).
-Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).
-Patented Drug Market: Prescription drug sales (USDbn & % of total sales).
-Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).
-OTC Drug Market: OTC sales (USDbn & % of total sales).
-Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against USD, government expenditure and external debt.
BMI?s Pharmaceuticals and Healthcare Risk Reward Index
About
Browse all Healthcare research reports at
You may also be interested in these related reports:
-Thailand Pharmaceuticals & Healthcare Report Q1 2016
-Pakistan Pharmaceuticals & Healthcare Report Q1 2016
-Argentina Pharmaceuticals & Healthcare Report Q1 2016
-Croatia Pharmaceuticals & Healthcare Report Q1 2016
-Puerto Rico Pharmaceuticals & Healthcare Report Q1 2016For more information on this press release visit: http://www.sbwire.com/press-releases/new-market-research-report-kenya-pharmaceuticals-healthcare-643444.htm
Media Relations Contact
Telephone: 800-844-8156
Email: Click to Email
Web: http://www.fastmr.com
Now Available: Governance, Risk and Compliance – the Bahraini Insurance Industry
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News